NCT07724327

Brief Summary

This study is a randomized controlled trial based on simulated clinical cases, aiming to establish a standardized evaluation system for PD physicians, to assess the differences in PD management quality between a workflow assisted by a PD-specialized large language model and physician-only decision-making, and to identify potential risks (such as generating obviously erroneous or even harmful recommendations). This simulated clinical case framework not only supports standardized and blinded evaluation, but also provides preliminary evidence for the model's effectiveness and safety before its deployment in real clinical settings, while avoiding direct impact on real patients.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
2mo left

Started Jul 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress27%
Jul 2026Sep 2026

First Submitted

Initial submission to the registry

June 28, 2026

Completed
12 days until next milestone

Study Start

First participant enrolled

July 10, 2026

Completed
14 days until next milestone

First Posted

Study publicly available on registry

July 24, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2026

Last Updated

July 24, 2026

Status Verified

July 1, 2026

Enrollment Period

2 months

First QC Date

June 28, 2026

Last Update Submit

July 20, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Management Reasoning

    Percent correct (range: 0 to 100) for each case.

    Within the 120-minute test period of the first test.

Secondary Outcomes (5)

  • Domain-Specific Scores

    Within the 120-minute test period of the first test.

  • Severity of Potential Harm

    Within the 120-minute test period of the first test.

  • Time per Scenario Case

    Within the 120-minute test period of the first test.

  • Self-Reported Confidence per Case

    Within the 120-minute test period of the first test.

  • Difference between the Phys group's scores when tested with PD-LLM assistance and when assisted only by traditional search methods

    After 1-2 months of washout of first test

Study Arms (2)

Phys Group

NO INTERVENTION

Participants could search for relevant knowledge, but access to large language model (LLM)-related websites was prohibited. Participants will be invited to test again with the assistance of PD-LLM after 1-2 months of washout.

Phys+PD-LLM Group

EXPERIMENTAL

Participants had access to the web and a specialized PD-LLM provided by the First Affiliated Hospital of Sun Yat-sen University.

Other: Peritoneal dialysis-specialized large language model.

Interventions

The peritoneal dialysis-specialized large language model (PD-LLM) used in this study was jointly developed by the Department of Nephrology at the First Affiliated Hospital of Sun Yat-sen University and Digital Health China (DHC).

Phys+PD-LLM Group

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Internal medicine or nephrology standardized training residents, licensed residents, or attending physicians.
  • Independent experience in PD management ≤ 3 years.
  • Provided signed informed consent and agreed to comply with the trial procedures.

You may not qualify if:

  • Direct involvement in the development or training of the specialized PD large language model, or in the construction of the clinical scenarios/ scoring criteria used in this trial.
  • Participation in the pilot testing of all clinical scenarios used in this trial.
  • Inability or unwillingness to access the study platform or use online resources during the study period.
  • Experienced PD experts.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital of Sun Yat-sen University

Guangzhou, Guangdong, 510080, China

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Vice President

Study Record Dates

First Submitted

June 28, 2026

First Posted

July 24, 2026

Study Start

July 10, 2026

Primary Completion (Estimated)

August 30, 2026

Study Completion (Estimated)

September 30, 2026

Last Updated

July 24, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Locations